1
/
의
1
Elabscience
SKU(재고 관리 코드):PKSH032264
Recombinant Human Coagulation Factor IX/F9 Protein (His Tag)
Recombinant Human Coagulation Factor IX/F9 Protein (His Tag)
Introducing the Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG), a cutting-edge product designed to address deficiencies in blood clotting factors. This meticulously engineered protein, derived from human sources, exhibits exceptional purity and potency, making it an indispensable tool in the field of hematology.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) is produced using advanced recombinant DNA technology, ensuring a high degree of consistency and reliability. Its formulation incorporates a histidine (HIS) tag, facilitating efficient purification and enabling seamless integration into various research and diagnostic applications.
This protein's primary function lies in its ability to restore the clotting cascade, thereby promoting hemostasis in individuals suffering from Factor IX deficiencies. Its remarkable affinity for binding to specific receptors on platelets and endothelial cells enhances its therapeutic potential, offering a targeted approach to managing bleeding disorders.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) boasts an extended half-life, allowing for prolonged efficacy and reduced dosing frequency. This attribute not only enhances patient convenience but also contributes to improved treatment outcomes and overall quality of life.
Furthermore, this product adheres to stringent quality control measures, ensuring batch-to-batch consistency and compliance with regulatory standards. Rigorous testing procedures guarantee the absence of contaminants, endotoxins, and adventitious agents, instilling confidence in its safety and reliability.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) is supplied in a lyophilized form, preserving its stability and facilitating long-term storage. Its user-friendly reconstitution process enables seamless integration into laboratory workflows, ensuring ease of use and convenience.
In summary, the Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) represents a breakthrough in the field of hematology, offering a highly purified and potent solution for addressing Factor IX deficiencies. With its exceptional therapeutic potential, extended half-life, and stringent quality control measures, this product stands as a reliable and indispensable tool for researchers, clinicians, and diagnostic laboratories alike.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) is produced using advanced recombinant DNA technology, ensuring a high degree of consistency and reliability. Its formulation incorporates a histidine (HIS) tag, facilitating efficient purification and enabling seamless integration into various research and diagnostic applications.
This protein's primary function lies in its ability to restore the clotting cascade, thereby promoting hemostasis in individuals suffering from Factor IX deficiencies. Its remarkable affinity for binding to specific receptors on platelets and endothelial cells enhances its therapeutic potential, offering a targeted approach to managing bleeding disorders.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) boasts an extended half-life, allowing for prolonged efficacy and reduced dosing frequency. This attribute not only enhances patient convenience but also contributes to improved treatment outcomes and overall quality of life.
Furthermore, this product adheres to stringent quality control measures, ensuring batch-to-batch consistency and compliance with regulatory standards. Rigorous testing procedures guarantee the absence of contaminants, endotoxins, and adventitious agents, instilling confidence in its safety and reliability.
The Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) is supplied in a lyophilized form, preserving its stability and facilitating long-term storage. Its user-friendly reconstitution process enables seamless integration into laboratory workflows, ensuring ease of use and convenience.
In summary, the Recombinant Human Coagulation Factor IX/F9 Protein (HIS TAG) represents a breakthrough in the field of hematology, offering a highly purified and potent solution for addressing Factor IX deficiencies. With its exceptional therapeutic potential, extended half-life, and stringent quality control measures, this product stands as a reliable and indispensable tool for researchers, clinicians, and diagnostic laboratories alike.
